MDS experts Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss new trials presented in the last meeting of the American Society of Hematology (ASH) 2023. They focus on luspatercept, imetelstat and roxodustat.

New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]

This new initiative of the MDS Foundation is devoted to patients, family members, and other non-professional interested people. In each episode, experts in the field will discuss novel information on MDS, such as new diagnostic techniques, new therapies etc. They will also answer frequently asked questions, which are relevant to many people.

Share New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]

Sign up to save your podcasts

New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]

New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]